Add to ORKGTo evaluate hypothalamic-pituitary-adrenal (HPA) axis function in patients with recent onset polymyalgia rheumatica (PMR) not previously treated with glucocorticoids; and to detect possible correlations between adrenal hormone levels, interleukin 6 (IL-6), and other acute phase reactants at baseline and during 12 months of glucocorticoid treatment
Objective. To determine laboratory parameters that may be useful in identifying polymyalgia rheumati...
Summary Pain and fatigue have been identified as core symptoms of fibromyalgia syndrome (FMS). Since...
Objective. To determine whether deficient activity of the hypothalamic corticotropin-releasing hormo...
To evaluate hypothalamic-pituitary-adrenal (HPA) axis function in patients with recent onset polymya...
glucocorticoid treatment on adrenal hormones and interleukin 6. Adrenal gland hypofunction in active...
This paper aims to evaluate adrenal gland hormone levels in patients with polymyalgia rheumatica (PM...
Objective: To explore the hypothalamic-pituitary-adrenal ( HPA) axis in polymyalgia rheumatica ( PMR...
Glucocorticoids are the mainstay of treatment in patients with polymyalgia rheumatica (PMR). Moreove...
Polymyalgia rheumatica (PMR) usually exhibits a good clinical response to glucocorticoid (GC) treatm...
Polymyalgia rheumatica (PMR) usually exhibits a good clinical response to glucocorticoid (GC) treatm...
Suppression of the hypothalamic-pituitary-adrenal (HPA) axis is a serious complication of systemic g...
Glucocorticoids (GLs) are the sole therapeutic approach in polymyalgia rheumatica (PMR). An undefine...
Suppression of the hypothalamic-pituitary-adrenal (HPA) axis is a serious complication of systemic g...
Background: Polymyalgia rheumatica (PMR) may create some difficulties in the differential diagnosis ...
Glucocorticoids (GC) are the mainstay of treatment of polymyalgia rheumatica (PMR). However GC-relat...
Objective. To determine laboratory parameters that may be useful in identifying polymyalgia rheumati...
Summary Pain and fatigue have been identified as core symptoms of fibromyalgia syndrome (FMS). Since...
Objective. To determine whether deficient activity of the hypothalamic corticotropin-releasing hormo...
To evaluate hypothalamic-pituitary-adrenal (HPA) axis function in patients with recent onset polymya...
glucocorticoid treatment on adrenal hormones and interleukin 6. Adrenal gland hypofunction in active...
This paper aims to evaluate adrenal gland hormone levels in patients with polymyalgia rheumatica (PM...
Objective: To explore the hypothalamic-pituitary-adrenal ( HPA) axis in polymyalgia rheumatica ( PMR...
Glucocorticoids are the mainstay of treatment in patients with polymyalgia rheumatica (PMR). Moreove...
Polymyalgia rheumatica (PMR) usually exhibits a good clinical response to glucocorticoid (GC) treatm...
Polymyalgia rheumatica (PMR) usually exhibits a good clinical response to glucocorticoid (GC) treatm...
Suppression of the hypothalamic-pituitary-adrenal (HPA) axis is a serious complication of systemic g...
Glucocorticoids (GLs) are the sole therapeutic approach in polymyalgia rheumatica (PMR). An undefine...
Suppression of the hypothalamic-pituitary-adrenal (HPA) axis is a serious complication of systemic g...
Background: Polymyalgia rheumatica (PMR) may create some difficulties in the differential diagnosis ...
Glucocorticoids (GC) are the mainstay of treatment of polymyalgia rheumatica (PMR). However GC-relat...
Objective. To determine laboratory parameters that may be useful in identifying polymyalgia rheumati...
Summary Pain and fatigue have been identified as core symptoms of fibromyalgia syndrome (FMS). Since...
Objective. To determine whether deficient activity of the hypothalamic corticotropin-releasing hormo...